Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 1.21 is 55% below its 5-year average of 2.68, near the low end of its 5-year range (1.02–7.30).
As of the fiscal period ended Tuesday, June 30, 2026. 4.71% above its 12-month average of 1.16.
Reported quarterly current ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 1.21.
CURRENT RATIO
1.21
CURRENT RATIO AVG TTM
1.16
CURRENT RATIO AVG 3Y
1.60
CURRENT RATIO AVG 5Y
2.68
CURRENT RATIO AVG 10Y
3.30
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+4.71%
CURRENT VS 3Y AVG
-24.26%
CURRENT VS 5Y AVG
-54.83%
CURRENT VS 10Y AVG
-63.37%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.48
median of 691 covered companies
CURRENT VS SECTOR MEDIAN
-65.24%
vs the sector median at left
Market Cap
$94.01M
Current Ratio
4.50
TTM Avg
8.19
3Y Avg
12.95
5Y Avg
15.06
Market Cap
$89.33M
Current Ratio
7.70
TTM Avg
11.16
3Y Avg
14.97
5Y Avg
23.58
Market Cap
$96.58M
Current Ratio
1.12
TTM Avg
0.73
3Y Avg
0.59
5Y Avg
0.59
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| electroCore, Inc. (ECOR) | $91.51M | 1.21 | 1.16 | 1.60 | 2.68 |
| Equillium, Inc. (EQ)vs › | $92.31M | 23.40 | 7.13 | 4.61 | 6.59 |
| Conexeu Sciences Inc. (CNXU)vs › | $93.47M | N/A | N/A | N/A | N/A |
| Biomea Fusion, Inc. (BMEA)vs › | $93.27M | 3.47 | 4.19 | 5.60 | 16.48 |
| Neumora Therapeutics, Inc. Common Stock (NMRA)vs › | $94.01M | 4.50 | 8.19 | 12.95 | 15.06 |
| PMV Pharmaceuticals, Inc. (PMVP)vs › | $89.33M | 7.70 | 11.16 | 14.97 | 23.58 |
| ImmuCell Corporation (ICCC)vs › | $89.11M | 4.75 | 3.83 | 3.74 | 4.48 |
| Park Dental Partners, Inc. Common Stock (PARK)vs › | $96.58M | 1.12 | 0.73 | 0.59 | 0.59 |
| CareCloud, Inc. (CCLD)vs › | $86.90M | 1.02 | 1.16 | 1.22 | 1.27 |
| Atara Biotherapeutics, Inc. (ATRA)vs › | $85.01M | 1.98 | 0.65 | 1.44 | 2.62 |
Current Ratio
1.21
Quick Ratio
1.00
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-06-30 | 1.21 |
| 2026-03-31 | 1.02 |
| 2025-12-31 | 1.02 |
| 2025-09-30 | 1.43 |
| 2025-06-30 | 1.10 |
| 2025-03-31 | 1.52 |
| 2024-12-31 | 1.78 |
| 2024-09-30 | 2.12 |
| 2024-06-30 | 2.48 |
| 2024-03-31 | 1.50 |
| 2023-12-31 | 1.76 |
| 2023-09-30 | 2.10 |
| 2023-06-30 | 1.73 |
| 2023-03-31 | 2.63 |
| 2022-12-31 | 3.01 |
| 2022-09-30 | 3.81 |
| 2022-06-30 | 5.16 |
| 2022-03-31 | 6.94 |
| 2021-12-31 | 6.84 |
| 2021-09-30 | 7.30 |
| 2021-06-30 | 4.41 |
| 2021-03-31 | 5.16 |
| 2020-12-31 | 4.26 |
| 2020-09-30 | 4.92 |
| 2020-06-30 | 3.92 |
| 2020-03-31 | 2.37 |
| 2019-12-31 | 2.90 |
| 2019-09-30 | 3.80 |
| 2019-06-30 | 6.63 |
| 2019-03-31 | 10.74 |
| 2018-12-31 | 10.28 |
| 2018-09-30 | 17.82 |
| 2018-06-30 | 14.42 |
| 2018-03-31 | 4.10 |
| 2017-12-31 | 6.38 |
| 2017-09-30 | 0.00 |
| 2017-06-30 | 0.00 |
| 2017-03-31 | 0.00 |
